We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
(+4%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Honeywell
HON
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$159M |
| 4 |
Amazon
AMZN
|
+$91M |
| 5 |
Tesla
TSLA
|
+$89.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.3M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$42.3M |
| 3 |
Magnite
MGNI
|
+$36.1M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$34.8M |
| 5 |
Etsy
ETSY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Communication Services | 10.72% |
| 4 | Healthcare | 9.96% |
| 5 | Financials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Macerich
MAC
$7.32B
| $706K | ﹤0.01% |
42,236
-21,801
| -34% | -$370K |
|
1027
UiPath
PATH
$5.62B
| $706K | ﹤0.01% |
+13,420
| New | +$812K |
|
1028
Sprout Social
SPT
$455M
| $706K | ﹤0.01% |
5,786
-5,762
| -50% | -$626K |
|
1029
Upwork
UPWK
$1.09B
| $704K | ﹤0.01% |
15,637
-14,625
| -48% | -$713K |
|
1030
Ambarella
AMBA
$2.99B
| $698K | ﹤0.01% |
4,481
-4,586
| -51% | -$527K |
|
1031
Ironwood Pharmaceuticals
IRWD
$611M
| $698K | ﹤0.01% |
53,419
-13,372
| -20% | -$173K |
|
1032
Novanta
NOVT
$5.04B
| $698K | ﹤0.01% |
4,521
-4,634
| -51% | -$674K |
|
1033
Tandem Diabetes Care
TNDM
$1.17B
| $698K | ﹤0.01% |
5,847
+3,582
| +158% | +$395K |
|
1034
Middleby
MIDD
$6.05B
| $697K | ﹤0.01% |
4,089
-509
| -11% | -$92K |
|
1035
Option Care Health
OPCH
$3.4B
| $697K | ﹤0.01% |
28,744
+42
| +0.1% | +$974 |
|
1036
Agree Realty
ADC
$9.68B
| $695K | ﹤0.01% |
10,498
-8,802
| -46% | -$641K |
|
1037
Encompass Health
EHC
$11.2B
| $694K | ﹤0.01% |
11,621
-2,371
| -17% | -$149K |
|
1038
Antero Resources
AR
$10.9B
| $693K | ﹤0.01% |
36,866
-37,579
| -50% | -$549K |
|
1039
Xencor
XNCR
$1.44B
| $693K | ﹤0.01% |
21,213
-5,497
| -21% | -$181K |
|
|
UMPQ
1040
DELISTED
Umpqua Holdings Corp
UMPQ
| $693K | ﹤0.01% |
34,209
-1,391
| -4% | -$26.7K |
|
1041
Chemours
CC
$2.59B
| $690K | ﹤0.01% |
23,749
-2,912
| -11% | -$94.3K |
|
1042
Lear
LEA
$7.19B
| $687K | ﹤0.01% |
4,388
+74
| +2% | +$12.1K |
|
1043
Alcoa
AA
$11.7B
| $685K | ﹤0.01% |
14,001
-2,007
| -13% | -$84.8K |
|
1044
Kinsale Capital Group
KNSL
$7.95B
| $684K | ﹤0.01% |
4,233
-2,968
| -41% | -$515K |
|
|
NUVA
1045
DELISTED
NuVasive, Inc.
NUVA
| $684K | ﹤0.01% |
11,426
-7,783
| -41% | -$480K |
|
1046
Commault Systems
CVLT
$5.89B
| $681K | ﹤0.01% |
9,044
-5,387
| -37% | -$418K |
|
|
JBTM
1047
JBT Marel
JBTM
$7.14B
| $681K | ﹤0.01% |
4,842
-4,163
| -46% | -$597K |
|
1048
Chemed
CHE
$6.78B
| $679K | ﹤0.01% |
1,459
-321
| -18% | -$151K |
|
|
RVNC
1049
DELISTED
Revance Therapeutics, Inc.
RVNC
| $678K | ﹤0.01% |
24,340
-6,722
| -22% | -$192K |
|
1050
Cracker Barrel
CBRL
$1.2B
| $671K | ﹤0.01% |
4,798
-3,258
| -40% | -$456K |
|
Similar funds
ProShare Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.
- ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
- ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
- ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
- ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
- ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
- ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
- ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.